Autolus Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $10,091 | $1,775 |
Gross Profit | -223 | -1,895 | 8,285 | |
EBITDA | -69,448 | -46,152 | -31,623 | -32,907 |
EBIT | -71,386 | -48,047 | -33,429 | -34,682 |
Net Income | -82,094 | -58,272 | -52,690 | -77,171 |
Net Change In Cash | 0 | 0 | 10,091 | 1,775 |
Free Cash Flow | -86,329 | -51,924 | -41,046 | -26,309 |
Cash | 657,067 | 705,939 | 759,544 | 239,566 |
Basic Shares | 266,084 | 266,025 | 222,170 | 174,029 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $1,698 | $6,194 | $2,330 | $242 |
Gross Profit | -4,867 | -131,026 | -126,321 | -134,646 |
EBITDA | -156,770 | -135,536 | -132,006 | -160,508 |
EBIT | -163,335 | -142,958 | -140,554 | -166,257 |
Net Income | -208,383 | -148,839 | -142,096 | -142,094 |
Net Change In Cash | 1,698 | 6,194 | 2,330 | 242 |
Free Cash Flow | -156,573 | -123,149 | -126,718 | -132,439 |
Cash | 239,566 | 382,436 | 310,338 | 153,299 |
Basic Shares | 173,941 | 94,993 | 72,084 | 51,558 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.31 |
2024-06-30 | -$0.22 |
2024-03-31 | -$0.24 |
2023-12-31 | -$0.45 |
